0001140361-17-022037.txt : 20170523 0001140361-17-022037.hdr.sgml : 20170523 20170523180352 ACCESSION NUMBER: 0001140361-17-022037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170519 FILED AS OF DATE: 20170523 DATE AS OF CHANGE: 20170523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Kenneth W. CENTRAL INDEX KEY: 0001530777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 17864961 MAIL ADDRESS: STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC. STREET 2: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 4 1 doc1.xml FORM 4 X0306 4 2017-05-19 0 0000722723 HANGER, INC. HGR 0001530777 Wilson Kenneth W. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Pres./COO Southern Prosthetic* Common Stock 52632 D Stock Options (right to buy) 12.77 2017-05-19 4 A 0 54834 0 A 2027-05-19 Common Stock 54834 54834 D Performance Share Units 2017-05-19 4 A 0 21934 0 A 2020-05-19 Common Stock 21934 21934 D Includes (i) unvested restricted shares which total 11,000 shares of stock from an initial grant of 11,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 10,155 shares of stock from an initial grant of 11,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 5,320 shares of stock from an initial grant of 6,359 shares of restricted stock made on March 6, 2015; (v) unvested restricted shares and fully vested shares totaling 3,063 shares of stock from an initial grant of 3,661 shares of restricted stock made on March 7, 2014; [continued in next footnote] (vi) unvested restricted shares and fully vested shares totaling 5,839 shares of stock from an initial grant of 8,075 shares of restricted stock and performance shares made on March 11, 2013; (vii) fully vested shares totaling 6,833 shares of stock from an initial grant of 13,800 shares of restricted stock and performance shares made on March 7, 2012 and (viii) fully vested shares totaling 5,422 shares of stock from an initial grant of 15,000 shares of restricted stock made on September 19, 2011. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. * President and Chief Operating Officer of Southern Prosthetic Supply, Inc. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Kenneth W. Wilson 2017-05-23